Received: 21 September 2020
Accepted: 17 November 2020
First Online: 19 February 2021
Ethics approval and consent to participate
: This study was conducted in accordance with the fundamental principles of the Declaration of Helsinki. The case report is part of the project “OncoDeep Immune RNA-seq panel for predicting response to immunotherapy in recurrent locally advanced or metastatasic, NSCLC: a pilot study” approved by the ethical committee of Complejo Asistencial Universitario de Burgos.
: Written informed consent was obtained from the patient for the publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: The authors declare that they have no competing interests.